Shari Traiger
About Shari Traiger
Shari Traiger is a Clinical Account Specialist with a background in bioengineering and business analytics. She has held various roles in clinical and research settings, including positions at Biosense Webster and the University of Massachusetts Amherst.
Current Role at Biosense Webster
Shari Traiger currently serves as a Clinical Account Specialist at Biosense Webster. She has been in this role since 2022, contributing to the company's mission in the medical device sector. Her responsibilities include managing clinical accounts and supporting healthcare professionals in the use of Biosense Webster products.
Previous Experience at Biosense Webster
Prior to her current position, Shari Traiger worked as an Associate Clinical Account Specialist at Biosense Webster from 2021 to 2022. In this role, she gained valuable experience in clinical account management and developed skills that supported her transition to her current position.
Educational Background in Engineering
Shari Traiger earned a Bachelor of Science degree in Bioengineering and Biomedical Engineering from the University of Massachusetts Amherst, completing her studies from 2017 to 2021. This educational foundation provided her with a strong understanding of engineering principles and applications in the biomedical field.
Advanced Studies in Business and Analytics
Shari is currently pursuing a Master's degree in Business and Analytics at the Isenberg School of Management, UMass Amherst. She began her graduate studies in 2021 and is expected to complete the program in 2025. This advanced education complements her technical background with business acumen.
Professional Experience in Research and Leadership
Shari Traiger has held various positions that demonstrate her leadership and research skills. She worked as a Camp Division Head at Camp Ramah In New England from 2017 to 2021, where she managed camp operations. Additionally, she served as an Undergraduate Research Assistant at the UMass Institute for Applied Life Sciences from 2018 to 2020, contributing to research projects in applied life sciences.